Ropes & Gray represented Bain Capital Life Sciences as it led an over $200 million strategic growth transaction centered on Serán Bioscience, a leading contract development and manufacturing organization (CDMO) providing development, analytical and manufacturing services to pharmaceutical and biotechnology companies. The transaction was announced on September 17.
Bain Capital Life Sciences invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.
The Ropes & Gray team was led by venture capital & emerging companies and life sciences partner Rajarshi Banerjee, private equity transactions partner Oliver Nip, strategic transaction partner Arthur Mok, and life sciences partner Michael Beauvais, and included finance partner Daniel Coyne, tax partner Pamela Glazier, employment law partner Meg Bisk, executive compensation & employee benefits partner Renata Ferrari, litigation & enforcement partners Brendan Hanifin and Lisa Kaltenbrunner, litigation & enforcement counsel Deidre Johnson, venture capital & emerging companies counsel Ray Grant, private equity counsel Boxin Wang, and private equity associate Connie Shen.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.